ArticleTrials2019

A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC).

Mitchell L Ramsey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.